Sen. Elizabeth Warren (D-MA) (Jacquelyn Martin/AP Images)
August 12, 2024 03:55 PM EDT
Pharma
FDA+
Law

Law­mak­ers re­new calls for gov­ern­ment to fi­nal­ize march-in guid­ance

Nicole DeFeudis

Editor

Sens. Eliz­a­beth War­ren (D-MA) and An­gus King (I-ME), and Rep. Lloyd Doggett (D-TX) are once again urg­ing the fed­er­al gov­ern­ment to “im­me­di­ate­ly strength­en and fi­nal­ize …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Out­look's shares crash as wet AMD drug flunks Phase 3 test

A service from the Financial Times